The trademark application formulate was filed by Formulate Bioscience, Inc., a U.S. corporation (the "Applicant"). The application was published for oppositions on September 23, 2021, and it was registered by office on January 5, 2022 without any oppositions.
The application was filed in English (French was selected as the second language).
Goods And Services
The mark was filed in class 5 with following description of goods:
Pharmaceutical preparations
Human endocannabinoid system-based therapeutic products
Therapeutic agents for binding and activating encannabinoid receptors.
The mark was filed in class 42 with following description of goods:
Pharmaceutical research and development services
Research and development services in the field of endocannabinoid systems
Providing medical and scientific research information in the field of endocannabinoid systems and endocannabinoid system-based therapies.